Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02431871 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sequelae of Developmental Dysplasia of the Hip

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv7
  2. Notable Primary completion date: Aug 2021 to Dec 2022v6
  3. Minor Primary completion date: Mar 2021 to Aug 2021v5
  4. Notable Primary completion date: Dec 2019 to Mar 2021
    • Eligibility criteria revised
    • Secondary endpoints: details revised at 1 of 4 entries
    • Study description shortened, about 1 word
    v4
  5. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v3
  6. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to assess long term effects of developmental dysplasia of the hip (DDH) to overall health and quality of life later in life. We compare hip radiographs, hip symptoms, clinical examination, head asymmetry, dental examination and intraoral scans of 170 children and young adults treated for DDH in their childhood with age and sex matched controls.
Trial Details
NCT Number NCT02431871
Lead Sponsor University of Oulu
Conditions
(from sponsor)
Developmental Dysplasia of the Hip, Hip Dysplasia
Related terms Developmental Dysplasia of the Hip, Hip Dislocation
Enrollment 340 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov